HMGCR and myopathy: Therefore, although they are a valid indicator of anti-HMGCR myopathy, anti-HMCGCR autoantibody tests should be reserved for patients with a high pretest probability (i.e., symptomatic elderly subjects exposed to statins) to improve their positive predictive value and reduce the likelihood of alternative diagnoses [9].